Cargando…
Optimal Endoscopic Treatment and Surveillance of Serrated Polyps
Serrated polyps are considered precursor lesions that account for 15% to 30% of colorectal cancers, and they are overrepresented as a cause of interval cancers. They are difficult to detect and resect comprehensively; however, recent data suggest that high definition endoscopy, chromoendoscopy (via...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366140/ https://www.ncbi.nlm.nih.gov/pubmed/31581390 http://dx.doi.org/10.5009/gnl19202 |
_version_ | 1783560172152553472 |
---|---|
author | Gupta, Vipin East, James E. |
author_facet | Gupta, Vipin East, James E. |
author_sort | Gupta, Vipin |
collection | PubMed |
description | Serrated polyps are considered precursor lesions that account for 15% to 30% of colorectal cancers, and they are overrepresented as a cause of interval cancers. They are difficult to detect and resect comprehensively; however, recent data suggest that high definition endoscopy, chromoendoscopy (via spray catheter, pump or orally), narrow band imaging, split-dose bowel preparation and a slower withdrawal (>6 minutes) can all improve detection. Cold snare resection is effective and safe for these lesions, including cold snare piecemeal endoscopic mucosal resection, which is likely to become the standard of care for lesions >10 mm in size. Sessile serrated lesions ≥10 mm in size, those exhbiting dysplasia, or traditional serrated adenomas increase the chance of future advanced neoplasia. Thus, a consensus is emerging: a surveillance examination at 3 years should be recommended if these lesions are detected. Serrated lesions likely carry equivalent risk to adenomas, so future guidelines may consider serrated class lesions and adenomas together for risk stratification. Patients with serrated polyposis syndrome should undergo surveillance every 1 to 2 years once the colon is cleared of larger lesions, and their first degree relatives should undergo screening every 5 years starting at age 40. |
format | Online Article Text |
id | pubmed-7366140 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Editorial Office of Gut and Liver |
record_format | MEDLINE/PubMed |
spelling | pubmed-73661402020-07-27 Optimal Endoscopic Treatment and Surveillance of Serrated Polyps Gupta, Vipin East, James E. Gut Liver Review Serrated polyps are considered precursor lesions that account for 15% to 30% of colorectal cancers, and they are overrepresented as a cause of interval cancers. They are difficult to detect and resect comprehensively; however, recent data suggest that high definition endoscopy, chromoendoscopy (via spray catheter, pump or orally), narrow band imaging, split-dose bowel preparation and a slower withdrawal (>6 minutes) can all improve detection. Cold snare resection is effective and safe for these lesions, including cold snare piecemeal endoscopic mucosal resection, which is likely to become the standard of care for lesions >10 mm in size. Sessile serrated lesions ≥10 mm in size, those exhbiting dysplasia, or traditional serrated adenomas increase the chance of future advanced neoplasia. Thus, a consensus is emerging: a surveillance examination at 3 years should be recommended if these lesions are detected. Serrated lesions likely carry equivalent risk to adenomas, so future guidelines may consider serrated class lesions and adenomas together for risk stratification. Patients with serrated polyposis syndrome should undergo surveillance every 1 to 2 years once the colon is cleared of larger lesions, and their first degree relatives should undergo screening every 5 years starting at age 40. Editorial Office of Gut and Liver 2020-07-15 2019-08-08 /pmc/articles/PMC7366140/ /pubmed/31581390 http://dx.doi.org/10.5009/gnl19202 Text en Copyright © 2020 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Gupta, Vipin East, James E. Optimal Endoscopic Treatment and Surveillance of Serrated Polyps |
title | Optimal Endoscopic Treatment and Surveillance of Serrated Polyps |
title_full | Optimal Endoscopic Treatment and Surveillance of Serrated Polyps |
title_fullStr | Optimal Endoscopic Treatment and Surveillance of Serrated Polyps |
title_full_unstemmed | Optimal Endoscopic Treatment and Surveillance of Serrated Polyps |
title_short | Optimal Endoscopic Treatment and Surveillance of Serrated Polyps |
title_sort | optimal endoscopic treatment and surveillance of serrated polyps |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366140/ https://www.ncbi.nlm.nih.gov/pubmed/31581390 http://dx.doi.org/10.5009/gnl19202 |
work_keys_str_mv | AT guptavipin optimalendoscopictreatmentandsurveillanceofserratedpolyps AT eastjamese optimalendoscopictreatmentandsurveillanceofserratedpolyps |